Richard Hill

Stock Analyst at Morgan Stanley

(1.63)
# 3,450
Out of 5,112 analysts
277
Total ratings
52.88%
Success rate
-0.22%
Average return

Stocks Rated by Richard Hill

Healthpeak Properties
Aug 22, 2025
Maintains: Overweight
Price Target: $22$21
Current: $16.41
Upside: +27.97%
Ventas
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $70$75
Current: $79.91
Upside: -6.14%
Cushman & Wakefield
Jun 12, 2025
Maintains: Overweight
Price Target: $14$15
Current: $15.90
Upside: -8.81%
Safehold
Apr 29, 2025
Maintains: Equal-Weight
Price Target: $19$17
Current: $13.62
Upside: +24.82%
American Assets Trust
Apr 24, 2025
Maintains: Equal-Weight
Price Target: $24$20
Current: $19.01
Upside: +5.21%
SITE Centers
Sep 30, 2024
Maintains: Equal-Weight
Price Target: $56$57
Current: $6.34
Upside: +799.05%
RE/MAX Holdings
Nov 7, 2023
Downgrades: Underweight
Price Target: $20$9
Current: $8.00
Upside: +12.50%
Urban Edge Properties
Jul 11, 2023
Reiterates: Underweight
Price Target: $14
Current: $19.55
Upside: -28.39%
UDR, Inc.
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $54$49
Current: $36.12
Upside: +35.66%
Essex Property Trust
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $313$288
Current: $261.07
Upside: +10.32%
Maintains: Equal-Weight
Price Target: $83$75
Current: $62.09
Upside: +20.79%
Maintains: Overweight
Price Target: $242$225
Current: $181.23
Upside: +24.15%
Maintains: Equal-Weight
Price Target: $6.5$6.3
Current: $4.22
Upside: +49.29%
Maintains: Overweight
Price Target: $133$131
Current: $185.07
Upside: -29.22%
Maintains: Equal-Weight
Price Target: $58$62
Current: $67.71
Upside: -8.43%
Maintains: Equal-Weight
Price Target: $31$34
Current: $36.37
Upside: -6.52%
Maintains: Equal-Weight
Price Target: $22$24
Current: $20.28
Upside: +18.34%
Maintains: Overweight
Price Target: $41$45
Current: $27.41
Upside: +64.17%
Maintains: Equal-Weight
Price Target: $38$39
Current: $31.68
Upside: +23.11%
Maintains: Underweight
Price Target: $11$8.5
Current: $18.48
Upside: -54.00%
Maintains: Overweight
Price Target: $86$100
Current: $187.49
Upside: -46.66%
Reinstates: Equal-Weight
Price Target: $148
Current: $261.37
Upside: -43.38%